SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000059478-24-000258
Filing Date
2024-11-19
Accepted
2024-11-19 16:49:17
Documents
17
Period of Report
2024-11-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lly-20241119.htm   iXBRL 8-K 53253
2 EX-99.1 pr_november2024.htm EX-99.1 8664
7 image_0.jpg GRAPHIC 25646
8 image_1.jpg GRAPHIC 88186
  Complete submission text file 0000059478-24-000258.txt   444936

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lly-20241119.xsd EX-101.SCH 4497
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lly-20241119_def.xml EX-101.DEF 19611
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lly-20241119_lab.xml EX-101.LAB 37978
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lly-20241119_pre.xml EX-101.PRE 20830
19 EXTRACTED XBRL INSTANCE DOCUMENT lly-20241119_htm.xml XML 10543
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06351 | Film No.: 241476946
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)